In June 2026, Medtronic drew attention as analysts emphasized its positioning in cardiac ablation, diabetes care and ...

Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases has announced the first patient treated in its pivotal randomized trial of dNerva® targeted lung denervation ...

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it ...

Medtronic gains attention as renal denervation optimism, revenue growth, cardiac care, and diabetes technology reshape its ...

Egypt’s Healthcare Authority (EHA) said on Sunday its Fayrouz Medical Complex in South Sinai has successfully performed the ...

St. Anne's Hospital performs first renal denervation procedure to treat high blood pressure in Southeastern Massachusetts.

With 60 hedge funds holding bullish positions and analysts seeing 19.84% upside potential, Medtronic plc (NYSE:MDT) ranks among the top stocks to buy for financial stability. Medtronic plc (NYSE:MDT) ...

Retiree Marshall Evans found relief from severe hypertension through renal denervation, a minimally invasive kidney-based ...

Medtronic's 2026 acquisition strategy aligns with its recent hiring of a veteran J&J exec as the company's first-ever CFO of ...

Dr. Brian Kelly, a cardiologist with Novant Health, was in the studio to discuss new treatment advancements that offer ...